Therabron Therapeutics Secures New Orphan Designation for the Prevention of Bronchopulmonary Dysplasia

ROCKVILLE, MD — May 13, 2015 — Therabron Therapeutics, Inc. (Therabron), a specialty biotechnology company focused on the advancement of respiratory therapeutics with disease-modifying potential, today announced that the European […]

By |May 13th, 2015|Recent News|

Therabron Therapeutics Names Thomas F. Miller President and Chief Operating Officer

ROCKVILLE, MD, May 7, 2015 — Therabron Therapeutics, Inc. (Therabron), a specialty biotechnology company focused on the advancement of respiratory therapeutics with disease-modifying potential, announced that it has named Thomas […]

By |May 7th, 2015|Recent News|